Safety and efficacy of levodopa-carbidopa monotherapy in patients with advanced parkinson's disease

被引：2
|
作者：
Boyd, J. T. [1 ]
Zadikoff, C. [2 ]
Benesh, J. A. [3 ]
Zamudio, J. [4 ]
Robieson, W. Z. [5 ]
Kukreja, P. [4 ]
机构：
[1] Univ Vermont, Lamer Coll Med, Neurol Sci, Burlington, VT USA
[2] Northwestern Univ, Feinberg Sch Med, Neurol, Chicago, IL 60611 USA
[3] AbbVie Inc, Neurosci Dev, N Chicago, IL USA
[4] AbbVie Inc, Neurosci, N Chicago, IL USA
[5] AbbVie Inc, Stat, N Chicago, IL USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.525
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
498
引用
收藏
页码：182 / 183
页数：2
相关论文
共 50 条
  • [1] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson's Disease
    Boyd, James
    Zadikoff, Cindy
    Benesh, Janet
    Zamudio, Jorge
    Robieson, Weining
    Kukreja, Pavnit
    NEUROLOGY, 2018, 90
  • [2] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson's Disease
    Boyd, James
    Zadikoff, Cindy
    Benesh, Janet
    Zamudio, Jorge
    Robieson, Weining
    Kukreja, Pavnit
    MOVEMENT DISORDERS, 2018, 33 : S87 - S88
  • [3] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson's Disease
    Boyd, J.
    Zadikoff, C.
    Siddiqui, M.
    Benesh, J.
    Zamudio, J.
    Robieson, W.
    Kukreja, P.
    MOVEMENT DISORDERS, 2018, 33 : S166 - S167
  • [4] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients With Advanced Parkinson's Disease
    Boyd, J.
    Zadikoff, C.
    Benesh, J.
    Zamudio, J.
    Robieson, W.
    Kukreja, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 180 - 180
  • [5] Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson's Disease
    Londero, E.
    dos Santos, A. P.
    Braga, R.
    de Barros, R.
    dos Reis, L.
    Freire, G.
    MOVEMENT DISORDERS, 2021, 36 : S220 - S220
  • [6] Efficacy of levodopa-carbidopa intestinal gel compared to oral levodopa-carbidopa in advanced Parkinson's disease: Sensitivity and responder analyses
    Boyd, J. T.
    Fernandez, H. H.
    Slevin, J. T.
    Espay, A. J.
    Standaert, D. G.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S143
  • [7] Efficacy of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Subgroup analyses
    Standaert, D. G.
    Slevin, J. T.
    Espay, A. J.
    Boyd, J. T.
    Fernandez, H. H.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S144
  • [8] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
    Bohlega S
    Abou Al-Shaar H
    Alkhairallah T
    中华物理医学与康复杂志, 2016, (03) : 179 - 179
  • [9] Long-Term Safety and Efficacy of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Fernandez, Hubert H.
    Boyd, James T.
    Fung, Victor S. C.
    Lew, Mark F.
    Rodriguez, Ramon L.
    Slevin, John T.
    Standaert, David G.
    Zadikoff, Cindy
    Vanagunas, Arvydas D.
    Chatamra, Krai
    Eaton, Susan
    Facheris, Maurizio F.
    Hall, Coleen
    Robieson, Weining Z.
    Benesh, Janet
    Espay, Alberto J.
    MOVEMENT DISORDERS, 2018, 33 (06) : 928 - 936
  • [10] Effect of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Takei, T.
    Uozumi, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 742 - 742
12345